A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy
- 1 September 2005
- journal article
- research article
- Published by Elsevier in Brain & Development
- Vol. 27 (6) , 400-405
- https://doi.org/10.1016/j.braindev.2004.09.014
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 13 references indexed in Scilit:
- Diagnosis of Duchenne dystrophy by enhanced detection of small mutationsNeurology, 2001
- Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutationsAnnals of Neurology, 2001
- Sequence specificity of aminoglycoside-induced stop codon readthrough: Potential implications for treatment of Duchenne muscular dystrophyAnnals of Neurology, 2000
- Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx miceJournal of Clinical Investigation, 1999
- The structural and functional diversity of dystrophinNature Genetics, 1993
- Replicating myoblasts express a muscle-specific phenotype.Proceedings of the National Academy of Sciences, 1988
- Further studies of gene deletions that cause Duchenne and Becker muscular dystrophiesGenomics, 1988
- Dystrophin: The protein product of the duchenne muscular dystrophy locusCell, 1987
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987
- Developmental origins of skeletal muscle fibers: clonal analysis of myogenic cell lineages based on expression of fast and slow myosin heavy chains.Proceedings of the National Academy of Sciences, 1986